Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis

New England Journal of Medicine

Volumn 334, Issue 14, 1996, Pages 878-883

  Savin, Virginia J ^a,h   Sharma, Ram ^a   Sharma, Mukut ^a   Mccarthy, Ellen T ^a   Swan, Suzanne K ^b   Ellis, Eileen ^c   Lovell, Helen ^d   Warady, Bradley ^e   Gunwar, Sripad ^f   Chonko, Arnold M ^f   Artero, Mary ^g   Vincenti, Flavio ^g  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c ARKANSAS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e CHILDREN S MERCY HOSPITAL   (United States)

^f UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CORTICOSTEROID; DEXTRAN;

ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NEPHROTIC SYNDROME; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; ALBUMINS; ANIMALS; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MALE; PERMEABILITY; PLASMAPHERESIS; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE; REFERENCE VALUES;

EID: 13344285352     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199604043341402     Document Type: Article

References (40)

1. Trachtman H, Carroll F, Phadke K, et al Paucity of minimal-change lesion in children with early frequently relapsing steroid-responsive nephrotic syndrome. Am J Nephrol 1987,7.13-7.
2. Tiebosch AT, Wolters J, Frederik PF, van der Wiel TW, Zeppenfeldt E, van Breda Vriesman PJ Epidemiology of idiopathic glomerular disease: a prospective study. Kidney Int 1987,32:112-6.
3. Ingulli E, Tejani A. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 1991,5.393-7
4. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 1972,2 343-8
5. Malekzadeh MH, Heuser ET, Ettenger RB, et al Focal glomerulosclerosis and renal transplantation. J Pediatr 1979;95:249-54.
6. Lewis EJ. Recurrent focal sclerosis after renal transplantation Kidney Int 1982;22:315-23.
7. Verani RR, Hawkins EP Recurrent focal segmental glomerulosclerosis, a pathological study of the early lesion. Am J Nephrol 1986;6:263-70
8. Morales JM, Andres A, Prieto C, et al. Clinical and histological sequence of recurrent focal segmental glomerulosclerosis. Nephron 1988;48:241-2.
9. Senggutuvan P, Cameron JS, Hartley RB, et al. Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 1990,4:21-8.
10. Tibor N, Silva FG, Hogg RJ. Minimal change nephrotic syndrome-focal sclerosis complex. In: Tisher CC, Brenner BM, eds Renal pathology with clinical and functional correlations. Philadelphia: J.B. Lippincott, 1994.330-89
11. Zimmerman SW Plasmapheresis and dipyridamole for recurrent focal glomerularsclerosis. Nephron 1985;40:241-5.
12. Laufer J, Ettenger RB, Ho WG, Cohen AH, Marik JL, Fine RN Plasma exchange for recurrent nephrotic syndrome following renal transplantation. Transplantation 1988;46:540-2
13. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992,92:375-83.
14. Cochat P, Kassir A, Colon S, et al. Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol 1993;7:50-4.
15. Dantal J, Bigot E, Bogers W, et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994;330 7-14.
16. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994;23:574-81.
17. Savin VJ. Mechanisms of proteinuria in noninflammatory glomerular diseases Am J Kidney Dis 1993,21:347-62.
18. Lagrue G, Branellec A, Blanc C, et al. A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties Biomedicine 1975,23:73-5.
19. Boulton-Jones JM, Tulloch I, Dore B, McLay A. Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin Nephrol 1983;20:72-7.
20. Tomizawa S, Maruyama K, Nagasawa N, Suzuki S, Kuroume T Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome. Nephron 1985;41:157-60
21. Heslan JM, Branellec A, Laurent J, Lagrue G. The vascular permeability factor is a T lymphocyte product Nephron 1986;42:187-8.
22. Yoshizawa N, Kusumi Y, Matsumoto K, et al. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome. Nephron 1989;51 370-6.
23. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 1991;40:453-60.
24. Zimmerman SW. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerularsclerosis after renal transplantation Clin Nephrol 1984;22:32-8
25. Bakker WW, Baller JFK, van Luyk WHJ, van der Hem GK. Mononuclear blood cells from patients with minimal change nephrotic syndrome (MCNS) induce increased glomerular permeability in the rat kidney in vivo. Kidney Int 1986,30:633. abstract
26. Wilkinson AH, Gillespie C, Hartley B, Williams DG. Increase in proteinuna and reduction in number of anionic sites on the glomerular basement membrane in rabbits by infusion of human nephrotic plasma in vivo. Clin Sci 1989;77.43-8.
27. Savin VJ, Sharma R, Lovell HB, Welling DJ Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 1992;3:1260-9
28. Dileepan KN, Sharma R, Stechschulte D, Savin VJ Effect of superoxide exposure on albumin permeability of isolated rat glomeruli. J Lab Clin Med 1993;121:797-804.
29. Li JZ, Sharma R, Dileepan K, Savin VJ. Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid. Kidney Int 1994;46.1025-30.
30. Savin VJ, Johnson RJ, Couser WG. C5b-9 increases albumin permeability of isolated rat glomeruli in vitro. Kidney Int 1994;46:382-7.
31. Swan SK, Schnell S, Houghton DC, Barry JM, Bennett WM Membranous nephropathy in renal allograft recipients: a report of 11 cases. Clin Transplant 1991,5:90-3.
32. Savin VJ, Terreros DA. Filtration in single isolated mammalian glomeruli Kidney Int 1981,20 188-97
33. Work TS, Work E, eds. Laboratory techniques in biochemistry and molecular biology. Amsterdam: North-Holland, 1969.
34. Tejani AT, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 1988;33:729-34.
35. Morales JM, Andres A, Prieto C, Praga M, Millet VG, Rodicio JL. Ciclosporin-induced partial and transient improvement of nephrotic syndrome in recurrent focal segmental glomerulosclerosis Nephron 1989;53:283-4.
36. Ingulli E, Tejani A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children - a single-center experience. Transplantation 1991;51:401-5.
37. Mendoza SA, Tune BM. Treatment of childhood nephrotic syndrome. J Am Soc Nephrol 1992;3:889-94
38. Tejani A, Lieberman K A randomized placebo (PL) controlled double blind trial of cyclosporine (CSA) in steroid resistant (SR) idiopathic focal segmental glomerulosclerosis (focal segmental glomerulosclerosis) in children: a report of the New York, New Jersey Pediatric Nephrology Collaborative Study Group. J Am Soc Nephrol 1993;4:289. abstract.
39. Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974;2.566-60.
40. Winetz JA, Robertson CR, Golbetz HV, Carrie BJ, Salyer NR, Myers BD. The nature of the glomerular injury in minimal change and focal sclerosing glomerulopathies Am J Kidney Dis 1981;1.91-8